Log in

Systolic blood pressure and risk of cardiovascular disease in normotensive diabetic adults: a prospective cohort study

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Background

Currently, the special blood pressure (BP) target for normotensive diabetic patients has not been recommended. We investigated the optimal systolic blood pressure (SBP) for lower cardiovascular disease (CVD) risk in normotensive diabetic patients.

Methods

In this 12-year follow-up study using the participants of the Kailuan Study, we mainly compared which SBP, 90–119 mmHg or 120–129 mmHg, had a lower risk of occurrence of CVD (stroke and myocardial infarction) in the 3072 normotensive diabetic participants and 21,532 normotensive and non-diabetic participants, respectively. The SBP was expressed as a mean time-weighted cumulative (MTWC) SBP, calculated from the multiple measurements of SBP during the follow-up. Multivariate competing risk regression analyses were used for the analysis.

Results

We found that in normotensive diabetic participants, MTWC SBP of 120–129 mmHg was associated with a lower risk of CVD (HR = 0.69 [0.50–0.95]), myocardial infarction (HR = 0.48 [0.24–0.96]), and trending towards lower risk of stroke (HR = 0.80 [0.55–1.16]), compared to MTWC SBP of 90–119 mmHg. Sensitivity analyses confirmed the relationship between low SBP and increased CVD risk. Whereas, in the normotensive and non-diabetic participants, MTWC SBP of 90–119 mmHg vs 120–129 mmHg did not exhibit any difference in the risk of CVD occurrence (HR = 0.99 [0.83–1.18]).

Conclusions

The higher level of SBP in normotensive diabetic patients is especially associated with a lower risk of CVD occurrence.

Graphical Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. B. Williams, G. Mancia, W. Spiering et al. ESC/ESH Guidelines for the management of arterial hypertension. Eur. Heart J. 39, 3021–3104 (2018)

    Article  PubMed  Google Scholar 

  2. P.K. Whelton, R.M. Carey, W.S. Aronow et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 71, e127–e248 (2018)

    Article  PubMed  Google Scholar 

  3. Committee ADAPP, 10. Cardiovascular disease and risk management: standards of medical care in diabetes-2022. Diabetes Care 45, S144–s74 (2022)

    Article  Google Scholar 

  4. Z. Wu, C. **, A. Vaidya et al. Longitudinal patterns of blood pressure, incident cardiovascular events, and all-cause mortality in normotensive diabetic people. Hypertension (Dallas, Tex. : 1979) 68, 71–77 (2016)

    Article  CAS  PubMed  Google Scholar 

  5. P. Poredos, A. Spirkoska, L. Lezaic, M.B. Mijovski, M.K. Jezovnik, Patients with an inflamed atherosclerotic plaque have increased levels of circulating inflammatory markers. J. Atherosclerosis Thrombosis 24, 39–46 (2017)

    Article  CAS  Google Scholar 

  6. K. Park, M. Gross, D.H. Lee et al. Oxidative stress and insulin resistance: the coronary artery risk development in young adults study. Diabetes Care 32, 1302–1307 (2009)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. A. Undas, I. Wiek, E. Stêpien, K. Zmudka, W. Tracz, Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome. Diabetes Care 31, 1590–1595 (2008)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. J.A. Beckman, M.A. Creager, P. Libby, Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management. JAMA 287, 2570–2581 (2002)

    Article  CAS  PubMed  Google Scholar 

  9. R. Klein, B.E. Klein, K.E. Lee, K.J. Cruickshanks, S.E. Moss, The incidence of hypertension in insulin-dependent diabetes. Arch. Intern. Med. 156, 622–627 (1996)

    Article  CAS  PubMed  Google Scholar 

  10. S. Wu, Z. Huang, X. Yang et al. Prevalence of ideal cardiovascular health and its relationship with the 4-year cardiovascular events in a northern Chinese industrial city. Circul. Cardiovascular Qual. outcomes 5, 487–493 (2012)

    Article  Google Scholar 

  11. S. Wu, Y. Li, C. ** et al. Intra-individual variability of high-sensitivity C-reactive protein in Chinese general population. Int. J. Cardiol. 157, 75–79 (2012)

    Article  CAS  PubMed  Google Scholar 

  12. W. Li, C. **, A. Vaidya et al. Blood pressure trajectories and the risk of intracerebral hemorrhage and cerebral infarction: A prospective study. Hypertension (Dallas, Tex. : 1979) 70, 508–514 (2017)

    Article  CAS  PubMed  Google Scholar 

  13. Y. Zuo, D. Zheng, S. Chen et al. Baseline and cumulative blood pressure in predicting the occurrence of cardiovascular events. Front. Cardiovascular Med. 8, 735679 (2021)

    Article  CAS  Google Scholar 

  14. American Diabetes Association, 10. Cardiovascular disease and risk management: Standards of medical care in diabetes-2020. Diabetes Care 43, S111–s34 (2020)

    Article  Google Scholar 

  15. A. Wang, Y. Sun, X. Liu et al. Changes in proteinuria and the risk of myocardial infarction in people with diabetes or pre-diabetes: a prospective cohort study. Cardiovasc. Diabetol. 16, 104 (2017)

    Article  PubMed  PubMed Central  Google Scholar 

  16. M. Zhao, Y. Chen, M. Wang et al. Relationship between resting heart rate and incident heart failure in patients with hypertension: The Kailuan Cohort Study in China. J. Clin. Hypertens. (Greenwich). 22, 2325–2331 (2020)

    Article  PubMed  PubMed Central  Google Scholar 

  17. P. Ponikowski, A.A. Voors, S.D. Anker et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. J. heart Fail. 18, 891–975 (2016)

    Article  PubMed  Google Scholar 

  18. A.S. Levey, L.A. Stevens, C.H. Schmid et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604–612 (2009)

    Article  PubMed  PubMed Central  Google Scholar 

  19. Q. Zhang, A. Wang, S. Zhang et al. Asymptomatic polyvascular disease and the risks of cardiovascular events and all-cause death. Atherosclerosis 262, 1–7 (2017)

    Article  CAS  PubMed  Google Scholar 

  20. Stroke--1989, Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke 20, 1407–1431 (1989)

    Article  Google Scholar 

  21. H. Tunstall-Pedoe, K. Kuulasmaa, P. Amouyel, D. Arveiler, A.M. Rajakangas, A. Pajak, Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90, 583–612 (1994)

    Article  CAS  PubMed  Google Scholar 

  22. P.C. Austin, J.P. Fine, Practical recommendations for reporting Fine-Gray model analyses for competing risk data. Stat. Med. 36, 4391–4400 (2017)

    Article  PubMed  PubMed Central  Google Scholar 

  23. S. Durrleman, R. Simon, Flexible regression models with cubic splines. Stat. Med. 8, 551–561 (1989)

    Article  CAS  PubMed  Google Scholar 

  24. S. Beddhu, G.M. Chertow, T. Greene et al. Effects of intensive systolic blood pressure lowering on cardiovascular events and mortality in patients with type 2 diabetes mellitus on standard glycemic control and in those without diabetes mellitus: Reconciling Results From ACCORD BP and SPRINT. J. Am. Heart Assoc. 7, e009326 (2018)

    Article  PubMed  PubMed Central  Google Scholar 

  25. J.T. Wright Jr, J.D. Williamson, P.K. Whelton et al. A randomized trial of intensive versus standard blood-pressure control. N. Engl. J. Med. 373, 2103–2116 (2015)

    Article  CAS  PubMed  Google Scholar 

  26. Y. Shahin, J.A. Khan, I. Chetter, Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials. Atherosclerosis 221, 18–33 (2012)

    Article  CAS  PubMed  Google Scholar 

  27. G. Zhang, Y. Fan, Y. Qiu et al. Allisartan isoproxil improves endothelial function and vascular damage in patients with essential hypertension: a single-center, open-label, randomized controlled trial. Adv. Ther. 37, 3551–3561 (2020)

    Article  CAS  PubMed  Google Scholar 

  28. J. Karalliedde, A. Smith, L. DeAngelis et al. Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering. Hypertension (Dallas, Tex. : 1979) 51, 1617–1623 (2008)

    Article  CAS  PubMed  Google Scholar 

  29. K.T. Ong, S. Delerme, B. Pannier et al. Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients. J. Hypertension 29, 1034–1042 (2011)

    Article  CAS  Google Scholar 

  30. B.A. Bergmark, B.M. Scirica, P.G. Steg et al. Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk. Eur. heart J. 39, 2255–2262 (2018)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. M. Böhm, H. Schumacher, K.K. Teo et al. Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk. Eur. Heart J. 40, 2032–2043 (2019)

    Article  PubMed  Google Scholar 

  32. P.K. Whelton, R.M. Carey, W.S. Aronow et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 138, e426–e483 (2018)

    PubMed  Google Scholar 

  33. Y. Qi, X. Han, D. Zhao et al. Long-term cardiovascular risk associated with stage 1 hypertension defined by the 2017 ACC/AHA hypertension guideline. J. Am. Coll. Cardiol. 72, 1201–1210 (2018)

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank all the survey teams of the Kailuan Study group for their contribution and the study participants who contributed their information.

Funding

The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. This study was supported by National Key Research and Development Program of China (2022YFC3600600), Bei**g Natural Science Foundation Haidian original innovation joint fund (L222123), Fund for Young Talents of Bei**g Medical Management Center (QML20230505), and the high-level public health talents (xuekegugan-02-47).

Author information

Authors and Affiliations

Authors

Contributions

Y.Z. wrote the manuscript. S.C. participated in the data analysis. X.T. participated in the literature search. S.C. participated in the data collection, study management and study coordination. A.W. edited the English in the manuscript. S.W. and A.W. contributed to the discussion, and also reviewed and edited the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Shouling Wu or Anxin Wang.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Ethics approval

This study was approved by the Ethics Committees of Kailuan General Hospital (approval number: 2006-05) and the Bei**g Tiantan Hospital (approval number: 2010-014-01).

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zuo, Y., Chen, S., Tian, X. et al. Systolic blood pressure and risk of cardiovascular disease in normotensive diabetic adults: a prospective cohort study. Endocrine (2024). https://doi.org/10.1007/s12020-024-03803-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12020-024-03803-6

Keywords

Navigation